Melatonin
5 trials in this asset. Source: ClinicalTrials.gov, as of July 21, 2026.
Trials
5
Ongoing
2
Recruiting
1
Completed
2
Sites
33
Countries
2
Endpoints
27
Composite endpoints
0
Distinct sites and countries across this asset's trials. A site running several of its trials counts once, matching the map. All 27 linked ClinicalTrials.gov endpoints are classified into the categories below. Trial and endpoint linkage does not by itself establish treatment attribution for every endpoint.
Development
Where the program stands
Trials by phase
Trials by status
Evidence coverage
What this asset has been measured on
Endpoints grouped into outcome categories, ranked by how often they are measured across this asset's trials.
Most-measured metrics
Top 20 metrics across this asset's endpoints
Normalized metric codes are available for 4 of 27 classified ClinicalTrials.gov endpoints for this asset; the ranking below covers that coded subset.
1
1
1
1
Trials
Trials for this asset
Every trial for this asset, with the same search, filters, and sort as the Trials tab.
5 of 5
| Asset / Disease area | Key I/E criterion | Evidence | ||||||
|---|---|---|---|---|---|---|---|---|
| NCT00000171Study of Melatonin: Sleep Problems in Alzheimer's Disease | Melatonin Alzheimer’s disease | Alzheimer's disease | Ph 3 | Completed | 31 | - | 2 | |
| MCIThe Effect of Melatonin on Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment | Melatonin MCI / preclinical Alzheimer’s | MMSE 24-30 | Ph 2 | Unknown | 1 | Oct 2010 | - | |
| NCT03954899Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging | Melatonin Alzheimer’s disease, MCI / preclinical Alzheimer’s | CDR-SB ≤1 | Not applicable | Recruiting | 1 | Nov 2025 | - | |
| NCT06756828Effects of 3-Month Melatonin Treatment on Regional Cerebellar Structure and Blood Biomarkers in Alzheimer's Disease Spectrum | Melatonin Alzheimer’s disease | Age 60-90 | Not applicable | Not yet recruiting | 0 | Aug 2026 | - | |
| NCT03066518Effect of Melatonin on Sleep Quality in Patients Dementia | Melatonin Mixed / unspecified dementia | Age 60-95 | Ph 4 | Completed | 0 | Jan 2017 | 11 |
Showing 1-5 of 5 trials